ROYAL BANK OF CANADA - VERA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of VERA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$77,000
+42.6%
5,591
+67.4%
0.00%
Q2 2023$54,000
+315.4%
3,339
+94.8%
0.00%
Q1 2023$13,000
-73.5%
1,714
-32.3%
0.00%
Q4 2022$49,000
+226.7%
2,533
+277.5%
0.00%
Q3 2022$15,000
+87.5%
671
+16.1%
0.00%
Q2 2022$8,000
-75.0%
578
-56.9%
0.00%
Q1 2022$32,000
-55.6%
1,341
-50.3%
0.00%
Q4 2021$72,000
+453.8%
2,696
+245.6%
0.00%
Q3 2021$13,0007800.00%
Other shareholders
VERA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Abingworth LLP 2,960,231$57,280,47018.66%
Kynam Capital Management, LP 1,409,098$27,266,0464.18%
Sofinnova Investments, Inc. 3,181,442$61,560,9033.65%
Octagon Capital Advisors LP 665,156$12,870,7692.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 281,257$5,428,2601.68%
Vivo Capital, LLC 400,666$7,7530.89%
Eversept Partners, LP 411,308$7,958,8100.70%
Logos Global Management LP 285,000$5,514,7500.65%
Alphabet Inc. 301,580$5,835,5730.34%
CARNEGIE MELLON UNIVERSITY 16,060$310,7610.17%
View complete list of VERA THERAPEUTICS INC shareholders